NDC 51862-471-01 - Leena
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51862-471
- Requested NDC
- 51862-471-01
- Package NDCs from labels
- 51862-471-01, 51862-471-06
- Manufacturer
- Mayne Pharma Inc. | Patheon Inc.
- Effective date
- 2024-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Leena® (Norethindrone and Ethinyl Estradiol Tablets USP) | Mayne Pharma Inc. | Patheon Inc. | 2024-03-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51862-471-01 | EA - Each | 51862-471 | bc5b9f2c-aa83-41a2-9ace-2af0fa9d0d45 | 1 | 2018-01-12 |
| 51862-471-06 | EA - Each | 51862-471 | b16f5486-50d2-42df-8e1c-b4a9323d5d96 | 1 | 2016-09-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Emzahh | NORETHINDRONE | Aurobindo Pharma Limited | 197d31d3-eec8-49c7-9640-918ff138fea2 | 2023-04-10 | Warnings, Adverse reactions | T18F433X4S |
| Lyleq | NORETHINDRONE | Afaxys Pharma, LLC | c9f00a3e-c827-4066-bf85-079b3a20f25e | 2023-03-27 | Warnings, Adverse reactions | T18F433X4S |
| Etonogestrel and Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | a8cc104a-d522-49ad-af54-2f312b829b61 | 2022-09-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | Amneal Pharmaceuticals LLC | 5ee34c07-65af-42b8-a98f-e299ff90a8a1 | 2022-04-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Norelgestromin and Ethinly Estradiol | NORELGESTROMIN AND ETHINLY ESTRADIOL | Amneal Pharmaceuticals NY LLC | 36445b6a-e0f2-42f7-a8f3-5b80c90b87dd | 2022-03-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| XULANE | NORELGESTROMIN AND ETHINYL ESTRADIOL | Mylan Pharmaceuticals Inc. | f7848550-086a-43d8-8ae5-047f4b9e4382 | 2022-03-04 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Nora BE | NORETHINDRONE | Teva Pharmaceuticals, Inc. | 426ac898-7745-4645-bf9b-bae319e260e8 | 2022-02-28 | Warnings, Adverse reactions | T18F433X4S |
| Amethyst | LEVONORGESTREL AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | 99073fe0-eac8-44dd-abe6-623fa67d9e79 | 2022-01-31 | Warnings, Adverse reactions | 423D2T571U |
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 140c50d6-c931-423a-9aa0-526eae7ab93c | 2021-12-01 | Boxed warning, Warnings, Adverse reactions | T18F433X4S 423D2T571U |
| Incassia | NORETHINDRONE | Aurobindo Pharma Limited | 0b87cef0-610c-469d-92ba-4007f4bc3878 | 2021-09-14 | Warnings, Adverse reactions | T18F433X4S |
| Norethindrone | NORETHINDRONE | Proficient Rx LP | fb84b86e-5f1f-4c17-8b69-ff695c5faf55 | 2019-11-01 | Warnings, Adverse reactions | T18F433X4S |
| NORETHINDRONE | NORETHINDRONE | Mylan Pharmaceuticals Inc. | af851d82-b30f-463b-9dba-0437225dc1ee | 2018-10-23 | Boxed warning, Warnings, Adverse reactions | T18F433X4S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.